No Pharma Money
News & Reports
News January 6, 2020

The Week in Review in Prescription Drug Pricing

By P4ADNow Team

New year, new you, same prescription drug price hikes.

 
1. Business as Usual

  • Pharma rang in 2020 by unleashing hundreds of drug price hikes. Congressional action is sorely needed, for patients like Genevieve and all of us. — (Reuters) 

2. The Smirk

  • A look back at the big flashpoints in the decade drug pricing rose to the top of the nation’s conscience. Voter anger is set to explode in 2020. — (NPR) 

3. 2019

  • We’d be remiss not to reflect back on the progress made on drug pricing in 2019. Momentum continues to build. — (P4ADNow)

4. Encouraging

  • In California, the court has denied pharma’s attempt to block the implementation of AB 824, a law to deter collusive agreements that slow affordable prescription drugs from reaching the market. — (AG Xavier Becerra via Twitter)

5. Idea:

  • If we stop shoveling profits into Big Pharma executive pay packages, stock buybacks, and dividends, these companies would start behaving themselves, create actual innovative drugs, and stop robbing the public. — (NBC)

Stay Connected

Stay informed about the latest campaigns, policy developments, and ways to help lower prescription drug prices.